Locust Walk Partners Announces Appointment of Chris Ehrlich, Biotechnology
Industry and Venture Capital Veteran, as Managing
Firm to Establish Significant Life Sciences Footprint in the Bay Area
CAMBRIDGE, MA and SAN FRANCISCO, CA -- (Marketwired) -- 05/14/13 --
Locust Walk Partners, LLC, a transaction advisory firm that supports
biopharmaceutical companies, is pleased to announce that biotech
industry and venture capital veteran Chris Ehrlich has joined the
firm as Managing Director. Based in San Francisco, Mr. Ehrlich will
be responsible for expanding and managing the firm's west coast
Prior to Locust Walk, Mr. Ehrlich was a Managing Director at
InterWest Partners, during which time he served on the boards of KAI
Pharmaceuticals (acquired by Amgen) and Biomimetic Therapeutics, Inc.
(acquired by Wright Medical Technologies). He currently sits on the
boards of Transcept Pharmaceuticals (NASDAQ: TSPT), Carbylan
BioSurgery and Xenon Pharmaceuticals. Prior to joining InterWest, Mr.
Ehrlich was Director, Licensing and Business Development at Purdue
Pharma. In this position, he was responsible for developing and
executing a biologic oncology strategy, including in-licensing key
intellectual properties, establishing and managing collaborations
with biotechnology companies and participating in the commercial
operations of Purdue BioPharma, a biotechnology company located in
Princeton, NJ. Prior to joining Purdue, Mr. Ehrlich worked in
business development at Genentech, in venture capital at The U.S.
Russia Investment Fund, and in biotechnology strategy at LEK
"I am very pleased to be joining Locust Walk Partners at this
inflection point in its lifecycle," commented Mr. Ehrlich. "The firm
has built a high quality reputation for and demonstrated a track
record of success in executing high value strategic transactions. It
is an ideal platform from which to help companies achieve their
business and corporate development objectives."
"We are thrilled to have an individual of Chris' caliber on the
Locust Walk team and look forward to the significant value he will
bring to our firm and our clients," said Jay Mohr, Managing Director.
Geoff Meyerson, Managing Director, added "Chris' breadth of contacts
and industry knowledge will be an asset to our clients."
About Locust Walk Partners
Locust Walk Partners has an established
reputation for executing high-value transactions for prominent
biopharmaceutical clients. Our teams are composed of seasoned
operating executives who bring insight, analytics and discipline into
every deal process and strategic engagement.
We are located in the biotech hubs of Cambridge, MA and San
Francisco, CA. www.locustwalkpartners.com
Press spacebar to pause and continue. Press esc to stop.